AstraZeneca cites oversupply from competitors for global recall of COVID vaccine after admitting side effect concerns May 11, 2024Clotting issues certainly didn’t help.Centrist Editor@Centrist Editor•Published May 2024View full profile → Share
Community Discussion
Comment Policy